Cargando…
Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019
Coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome-coronavirus-2 is a worldwide public health emergency that will have a lasting generational impact in terms of mortality and economic devastation. Social distancing to prevent viral transmission and supportive care of infec...
Autores principales: | Betts, Brian C., Young, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314334/ https://www.ncbi.nlm.nih.gov/pubmed/32696001 http://dx.doi.org/10.1097/CCE.0000000000000138 |
Ejemplares similares
-
Commentary: When is less more?
por: Sinha, Pranava
Publicado: (2021) -
COVID-19: When more might be less
por: Mugnai, Giacomo, et al.
Publicado: (2021) -
Gastrointestinal endoscopy during COVID-19: when less is more
por: Edwards, Cathryn, et al.
Publicado: (2020) -
Deciphering the vedolizumab dosing conundrum in IBD: when less is more
por: Adolph, Timon Erik, et al.
Publicado: (2022) -
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
por: Liu, Bingwen, et al.
Publicado: (2020)